ANN ARBOR (WWJ) --NanoBio Corp. will get an initial contract of $5.5 million and up to $5 million more to devleop its nanoemulsion technology to improve the performance of flu vaccines. The grant came ...

NanoBio's lead vaccine candidate, NB-1008, is a seasonal influenza vaccine administered intranasally. In a recently completed Phase 1 clinical study, NB-1008 was well-tolerated and elicited both ...

Gift Article 10 Remaining As a subscriber, you have 10 articles to gift each month. Gifting allows recipients to access the article for free. Ann Arbor-based NanoBio Corp., considered by many as ...

There has been a recent eruption (sorry 'bout that) of research geared toward discovering the first vaccine to treat and/or prevent genital herpes. You can add one more contender — Michigan-based ...

NanoBio(R) Corporation today announced the promotion of David Peralta to chief executive officer. Mr. Peralta, who previously served as the company’s chief operating and financial officer, replaces ...

Nanoemulsion Adjuvanted Vaccines Continue to Demonstrate Positive Pre-Clinical Results in Genital Herpes, HIV and Chlamydia ANN ARBOR, Mich., (December 2, 2015) – NanoBio Corporation, a ...

ANN ARBOR, Mich., May 7, 2018 /PRNewswire/ -- NanoBio Corporation, a clinical-stage biopharmaceutical company, today announced that it has changed its corporate name to BlueWillow Biologics ® in ...

NanoBio® Announces Development of Nasal Vaccine for the Prevention of Urinary Tract Infections in Collaboration with the University of Michigan 53 Percent of Women Suffer from UTIs Annually; Treatment ...

ANN ARBOR, Mich. (October 13, 2009) -NanoBio Corporation today announced an award from the National Institute of Allergy and Infectious Diseases, a Division of The National Institute of Health, to ...

NanoBio will receive a subcontract of approximately $4.1 million over the research period to support efforts aimed at developing nanoemulsion-based mucosal vaccine adjuvants for a wide variety of ...

ANN ARBOR, Mich.--(BUSINESS WIRE)--Researchers from NanoBio Corporation and the University of Michigan Medical School today announced the receipt of a $1.5 million grant from the Department of Defense ...

The venture capital group Perseus has pumped $10 million dollars into NanoBio, bringing its total investment in the University of Michigan spin-off to $30 million. The developer has been working on ...